Balance Sheet - BELITE BIO, INC (BLTE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 492.42 | 145.15 | 88.16 | 42.09 | 17.34 | 25.62 |
| Accounts receivable, net | 0.72 | 0.59 | 0.87 | 0.02 | 0.02 | 0.04 |
| Inventories | -0.02 | |||||
| Other current assets | 1.13 | 1.33 | 0.92 | 0.72 | 0.06 | 0.01 |
| Total current assets | 494.27 | 147.07 | 89.94 | 42.81 | 17.43 | 25.67 |
| Total non-current assets | 286.28 | 5.06 | 4.70 | 1.47 | 0.92 | 0.07 |
| Total assets | 780.56 | 152.13 | 94.64 | 44.27 | 18.35 | 25.74 |
| Total current liabilities | 9.88 | 6.05 | 3.63 | 2.10 | 1.64 | 0.97 |
| Total non-current liabilities | 0.19 | 0.26 | 0.58 | 0.67 | 31.81 | 31.81 |
| Total liabilities | 10.07 | 6.31 | 4.21 | 2.77 | 33.44 | 32.78 |
| Total stockholders' equity | 770.49 | 145.82 | 90.43 | 41.50 | -15.09 | -7.04 |
| Common shares outstanding | 34 | 31 | 27 | 20 | 24 | 9 |
Show Quarterly Balance Sheet
Balance Sheet - BELITE BIO, INC (BLTE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.00 | 492.42 | 275.61 | 0.00 | 0.00 | 145.15 | 0.00 | 0.00 | 95.50 | 88.16 | 54.50 | 57.40 | 37.80 | 42.09 | 0.04 | 0.05 | 17.34 | 17.34 | 17.34 | 21.99 | 21.99 | 25.62 | 25.62 | 6.40 | 6.40 |
| Accounts receivable, net | 0.72 | 0.02 | 0.59 | 0.87 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | ||||||||||
| Inventories | 0.70 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |||||||||||||||||||
| Other current assets | 1.13 | 1.58 | 150.97 | 159.29 | 1.33 | 111.27 | 18.36 | 0.92 | 1.64 | 59.14 | 38.42 | 0.00 | 0.00 | 1.23 | 1.23 | 0.06 | 0.09 | 0.06 | 0.06 | 0.01 | 0.05 | 0.00 | 0.00 | ||
| Total current assets | 521.86 | 494.27 | 277.21 | 150.97 | 159.29 | 147.07 | 111.27 | 113.86 | 113.86 | 89.94 | 56.14 | 59.14 | 38.42 | 42.81 | 0.04 | 49.93 | 17.34 | 17.43 | 17.43 | 22.04 | 22.04 | 25.67 | 25.67 | 6.42 | 6.42 |
| Total non-current assets | 289.41 | 286.28 | 5.18 | 5.44 | 4.91 | 5.06 | 4.55 | 4.57 | 4.57 | 4.70 | 1.46 | 1.56 | 1.40 | 1.47 | 0.00 | 1.13 | -17.34 | 0.92 | 0.92 | 0.13 | 0.13 | 0.07 | 0.07 | 0.02 | 0.02 |
| Total assets | 811.27 | 780.56 | 282.39 | 156.41 | 164.20 | 152.13 | 115.82 | 118.43 | 118.43 | 94.64 | 57.60 | 60.70 | 39.82 | 44.27 | 44.27 | 51.06 | 18.35 | 18.35 | 18.35 | 22.17 | 22.17 | 25.74 | 25.74 | 6.44 | 6.44 |
| Total current liabilities | 9.88 | 8.07 | 6.52 | 6.13 | 6.05 | 3.62 | 3.84 | 3.63 | 4.80 | 0.00 | 4.65 | 2.10 | 0.00 | 0.00 | 1.43 | 1.64 | 1.64 | 1.00 | 1.00 | 0.97 | 0.97 | 0.24 | 0.24 | ||
| Total non-current liabilities | 0.19 | 0.25 | 0.26 | 4.68 | 0.58 | 4.80 | 4.98 | 7.95 | 0.67 | 1.43 | 31.81 | 7.95 | 7.95 | 7.95 | 31.81 | 7.95 | 7.95 | 7.95 | |||||||
| Total liabilities | 15.48 | 10.07 | 8.31 | 6.52 | 6.13 | 6.31 | 3.62 | 3.84 | 3.84 | 4.21 | 4.80 | 4.98 | 4.65 | 2.77 | 0.00 | 1.43 | 33.44 | 1.64 | 1.00 | 1.00 | 32.78 | 0.97 | 8.19 | 8.19 | |
| Total stockholders' equity | 795.79 | 770.49 | 274.08 | 149.89 | 158.07 | 145.82 | 112.20 | 114.59 | 114.59 | 90.43 | 52.79 | 55.72 | 35.17 | 41.50 | 0.04 | 49.63 | 16.71 | -15.09 | 16.71 | 21.17 | 21.17 | -7.04 | 24.77 | -1.76 | -1.76 |
| Common shares outstanding | 40 | 34 | 33 | 33 | 32 | 31 | 31 | 31 | 30 | 28 | 27 | 26 | 21 | 21 | 25 | 20 | 24 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 |